Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-14.75	-7.23	-6.30
Graham Fair Price	-28.35	0.03	0.05
PEG	-32.27	0.20	0.30
Price/Book	-16.27	0.29	0.35
Price/Cash Flow	91.68	-5.96	-71.70
Prices/Earnings	-66.72	-9.24	-5.54
Price/Sales	-4.16	1.13	1.18
Price/FCF	91.68	-5.96	-71.70
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	4.22	0.26	0.25
Operating Margin	46.90	-0.02	-0.05
ROA	48.61	< 0.005	-0.01
ROE	-0.02	< 0.005	49.78
ROIC	-0.01	< 0.005	57.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.01	-28.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.26	0.53	104.06
EPS QOQ	0.19	0.46	146.15
FCF QOQ	-1.46	-9.18	-527.67
Revenue QOQ	0.13	-0.12	-12.70
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	29.89	28.22	-5.56
Days Sales Outstanding (DSO)	0.00	61.15	100.00
Inventory Turnover	3.01	3.19	5.89
Debt/Capitalization	0.14	0.13	-1.77
Quick Ratio	1.58	2.05	29.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	0.08	0.08	1.11
Cash	0.05	0.05	-5.32
Capex	< 0.005	< 0.005	-4.13
Free Cash Flow	< 0.005	< 0.005	-917.90
Revenue	0.02	0.02	-11.67
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	2.12	2.21	4.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.88	38.06	101.62
Naive Interpretation	Member

06 - Financial Health · Bad

Rating